Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/113862
Title: | Altered blood gene expression of tumor-related genes (PRKCB, BECN1 and CDKN2A) in Alzheimer's disease |
Author: | Antonell, Anna Lladó Plarrumaní, Albert Sánchez del Valle Díaz, Raquel Sanfeliu i Pujol, Coral Casserras, Teresa Rami González, Lorena Muñoz-García, Cristina Dangla-Valls, Adrià Balasa, Mircea Boya, Patricia Kalko, Susana Molinuevo, José Luis |
Keywords: | Malalties neurodegeneratives Malaltia d'Alzheimer Expressió gènica Autofàgia Mitocondris Sang Neurodegenerative Diseases Alzheimer's disease Gene expression Autophagy Mitochondria Blood |
Issue Date: | 28-Oct-2015 |
Publisher: | Humana Press |
Abstract: | Alzheimer's disease (AD) is the most common of the neurodegenerative diseases. Recent diagnostic criteria have defined a preclinical disease phase during which neuropathological substrates are thought to be present in the brain. There is an urgent need to find measurable alterations in this phase as well as a good peripheral biomarker in the blood. We selected a cohort of 100 subjects (controls = 47; preclinical AD = 11; patients with AD = 42) and analyzed whole blood expression of 20 genes by quantitative polymerase chain reaction. The selected genes belonged to calcium-signaling, senescence and autophagy, and mitochondria/oxidative stress pathways. Additionally, two genes associated with an increased risk of developing AD (CLU and BIN1) were also analyzed. We detected significantly different gene expressions of BECN1 and PRKCB between the control and the AD groups; and, of CDKN2A between the control and the preclinical AD groups. Notably, these three genes are also considered tumor suppressor (CDKN2A and BECN1) or tumor promoter (PRKCB) genes. Gene-gene expression Pearson correlations were computed separately for controls and patients with AD. The significant correlations (p<0.001) were represented in a network analysis with Cytoscape tool, which suggested an uncoupling of mitochondriarelated genes in AD group. Whole blood is emerging as a valuable tissue in the study of the physiopathology of AD. |
Note: | Versió postprint del document publicat a: https://doi.org/10.1007/s12035-015-9483-9 |
It is part of: | Molecular Neurobiology, 2015, vol. 53, num. 9, p. 5902-5911 |
URI: | http://hdl.handle.net/2445/113862 |
Related resource: | https://doi.org/10.1007/s12035-015-9483-9 |
ISSN: | 0893-7648 |
Appears in Collections: | Articles publicats en revistes (Biomedicina) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
659719.pdf | 784.44 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.